The beneficial effects of roflumilast on lung function were initially demonstrated in patients with moderate-to-severe COPD and severe COPD.[ 266 , 267 ] Both studies showed a trend towards lesser exacerbations with the use of roflumilast.
← all excerpts
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.
1
—
—